The preemie formula lawsuit is one of the largest mass torts in the United States right now. Thousands of families are suing Abbott Laboratories and Mead Johnson, claiming their cow’s milk-based formulas caused necrotizing enterocolitis in premature infants.
As of 2026, more than 1,000 cases are consolidated in a federal multidistrict litigation in Illinois. Settlement talks are gaining momentum, and bellwether trials are shaping what payouts could look like.
This article covers everything you need to know. You’ll find settlement estimates, eligibility requirements, trial updates, the specific products involved, and a step-by-step filing guide.
Some of these babies needed emergency surgery. Others didn’t survive. The stakes in this litigation are enormous, and families deserve clear answers about where things stand.
Preemie Formula Lawsuit
The preemie formula lawsuit is a mass tort action against formula manufacturers who sold cow’s milk-based products to hospitals for premature infants. Families allege these companies knew their products increased the risk of necrotizing enterocolitis but failed to warn parents or doctors.
This litigation is centralized as MDL No. 3026 in the U.S. District Court for the Northern District of Illinois. Judge Rebecca R. Pallmeyer oversees the proceedings.
The core legal claims include product liability, failure to warn, and negligence. Plaintiffs argue that safer alternatives, like donor breast milk, were available. The manufacturers allegedly prioritized profits over infant safety.
| Detail | Info |
|---|---|
| MDL Number | 3026 |
| Court | Northern District of Illinois |
| Presiding Judge | Rebecca R. Pallmeyer |
| Primary Defendants | Abbott Laboratories, Mead Johnson (Reckitt Benckiser) |
| Number of Pending Cases | 1,000+ as of early 2026 |
| Key Legal Claims | Product liability, failure to warn, negligence |
The lawsuit isn’t about all baby formula. It’s specifically about products designed for premature babies in NICUs. These are specialized formulas that hospitals used when breast milk wasn’t available or sufficient.
What makes this case unusual is the vulnerability of the victims. These were the smallest, most fragile patients in any hospital. Their families trusted that the products being used were safe.
NEC Baby Formula Lawsuit
The NEC baby formula lawsuit refers to legal claims filed by families whose premature infants developed necrotizing enterocolitis after being fed bovine-based formula products. NEC is a devastating intestinal disease that primarily strikes babies born before 37 weeks.
NEC attacks the intestinal wall. Bacteria invade the tissue, causing inflammation, tissue death, and sometimes perforation. For premature infants, the condition can become life-threatening within hours.
Research published in medical journals over the past two decades has drawn a connection between cow’s milk-based formulas and higher NEC rates. Babies who received exclusively human breast milk had significantly lower NEC incidence.
Key facts about NEC in this lawsuit:
- NEC affects roughly 1 in 1,000 live births overall
- Among very low birth weight infants, rates climb to 5 to 10 percent
- Mortality rates for surgical NEC range from 20 to 50 percent
- Survivors often face lifelong complications including short bowel syndrome
The central argument is straightforward. Abbott and Mead Johnson had access to decades of medical literature showing bovine formula increased NEC risk. They chose not to add warnings to their labels. They continued marketing these products aggressively to NICUs.
This isn’t a situation where the science was unclear. Multiple peer-reviewed studies flagged the connection. The manufacturers allegedly ignored it.
Preemie Formula Lawsuit Settlement Amounts
Preemie formula lawsuit settlement amounts have not been finalized as of early 2026, but legal analysts project payouts ranging from $50,000 to over $5 million per case depending on the severity of injury. Cases involving infant death or severe long-term disability are expected to command the highest settlements.
Think of settlement tiers like a ladder. The more severe the harm, the higher the rung. A baby who developed mild NEC and recovered fully sits on a different tier than one who required multiple surgeries and now lives with short bowel syndrome.
| Injury Severity | Estimated Settlement Range |
|---|---|
| NEC requiring medical management only | $50,000 to $250,000 |
| NEC requiring surgery (single) | $250,000 to $1,000,000 |
| NEC requiring multiple surgeries | $1,000,000 to $3,000,000 |
| NEC resulting in short bowel syndrome | $2,000,000 to $4,000,000 |
| NEC resulting in infant death | $3,000,000 to $5,000,000+ |
These figures are projections based on bellwether trial outcomes, comparable mass tort settlements, and plaintiff attorney estimates. They are not guaranteed amounts.
Several factors influence where a specific case lands on this scale. Medical documentation is huge. So is the ability to prove that the specific formula brand was used during the infant’s NICU stay.
The first bellwether trial verdicts have given plaintiffs significant leverage. A large jury award sends a clear signal to defendants about what juries think of their conduct.
Key Takeaway: Settlement amounts in the preemie formula lawsuit could range from $50,000 to more than $5 million, with the most severe NEC injuries and wrongful death cases commanding the highest payouts.
Who Qualifies for Preemie Formula Lawsuit
You may qualify for the preemie formula lawsuit if your premature infant was fed a cow’s milk-based formula or human milk fortifier in the NICU and later developed necrotizing enterocolitis. Both living children and families who lost an infant to NEC may be eligible.
The eligibility criteria are specific. Not every baby who was in a NICU qualifies. The connection between the formula product and the NEC diagnosis is what matters.
Basic eligibility requirements:
- The infant was born premature (before 37 weeks gestational age)
- The infant was fed Similac or Enfamil bovine-based formula or fortifier products
- The infant was diagnosed with NEC (Stage 2 or Stage 3)
- NEC was diagnosed during or shortly after the NICU stay
- The family can obtain medical records documenting formula use and NEC diagnosis
Parents and legal guardians can file on behalf of the child. In wrongful death cases, surviving parents or the estate representative can bring the claim.
There’s an important distinction here. Babies who were fed breast milk exclusively and still developed NEC typically do not have a viable claim against formula manufacturers. The lawsuit targets the specific cow’s milk-based products.
| Qualification Factor | Required? |
|---|---|
| Premature birth (under 37 weeks) | Yes |
| Fed bovine-based formula or fortifier | Yes |
| Diagnosed with NEC (Stage 2 or 3) | Yes |
| Medical records available | Yes |
| Statute of limitations still open | Yes |
If you’re unsure whether your child’s situation fits, the first step is pulling your NICU medical records. Those records will show what your baby was fed and when.
NEC Lawsuit Update 2026
The NEC lawsuit entered 2026 with increasing momentum toward a potential global settlement. Bellwether trial results from late 2025 gave plaintiffs significant legal ammunition, and both sides have engaged in structured settlement discussions.
Here’s where things stand as of early 2026. The MDL continues to grow. New cases are being filed monthly. Judge Pallmeyer has pushed both sides toward mediation while allowing additional bellwether cases to move forward.
2026 timeline of key developments:
- Q1 2026: Ongoing mediation sessions between plaintiff leadership and defendants
- Q2 2026: Additional bellwether trials scheduled for selection
- Mid-2026: Potential settlement framework announcement
- Late 2026: If no global settlement, further individual trials proceed
The bellwether trial results matter enormously. When juries award large verdicts to plaintiffs, it pressures defendants to settle rather than risk repeated losses. That pressure is building right now.
Abbott Laboratories has taken the harder line in negotiations. Mead Johnson, now owned by Reckitt Benckiser, has shown somewhat more willingness to explore resolution. But neither company has admitted fault.
One thing worth watching: the science panel. The court has been evaluating expert testimony on causation. If the court rules that the general causation evidence is strong, meaning bovine formula does increase NEC risk, that removes a major defense obstacle.
2026 could be the year this litigation breaks wide open. Or it could be another year of preparation. Either way, families should have their claims filed.
Similac Preemie Formula Lawsuit
The Similac preemie formula lawsuit targets specific products made by Abbott Laboratories for use in neonatal intensive care units. Similac Special Care and Similac Human Milk Fortifier are the primary products at the center of these claims.
Abbott is one of the largest infant nutrition companies in the world. Their Similac line generates billions in annual revenue. The NICU-specific products are a smaller segment but carry enormous liability because of their use in the most vulnerable patient population.
Similac products named in the lawsuit:
- Similac Special Care (liquid formula for premature infants)
- Similac NeoSure (discharge formula for preemies)
- Similac Human Milk Fortifier (added to breast milk in NICUs)
- Similac Alimentum (hypoallergenic, named in some claims)
Plaintiffs allege that Abbott knew as early as the 1990s that bovine-based formulas carried higher NEC risks for premature infants. Internal documents obtained during discovery have reportedly shown company awareness of the medical literature linking cow’s milk protein to intestinal injury.
Despite this knowledge, Abbott allegedly continued marketing these products without NEC warnings. Hospital staff and parents were never told about the elevated risk. The company’s marketing materials reportedly emphasized the nutritional benefits while omitting safety concerns.
Abbott has denied liability. The company’s defense centers on the argument that NEC has multiple causes and that their products met all FDA regulatory requirements.
Key Takeaway: Similac Special Care and Similac Human Milk Fortifier are the primary Abbott products driving the preemie formula litigation, with plaintiffs alleging the company knew about NEC risks and failed to warn.
Enfamil Preemie Formula Lawsuit
The Enfamil preemie formula lawsuit targets products manufactured by Mead Johnson Nutrition, which is now a subsidiary of Reckitt Benckiser. Enfamil Premature and Enfamil Human Milk Fortifier are the key products named in these claims.
Mead Johnson held a significant share of the NICU formula market for decades. Their products were standard in hospitals across the country. Many parents never even knew which brand their baby was being fed because the decision was made by hospital staff.
Enfamil products named in the lawsuit:
- Enfamil Premature (specifically designed for preterm infants)
- Enfamil NeuroPro EnfaCare (for premature infants after discharge)
- Enfamil Human Milk Fortifier (bovine-based additive mixed with breast milk)
- Enfamil 24 and related concentrated formulas
The legal arguments against Mead Johnson mirror those against Abbott. Plaintiffs claim Mead Johnson had knowledge of the NEC risk associated with bovine-based formulas and failed to provide adequate warnings.
One complicating factor in the Enfamil cases is Reckitt Benckiser’s acquisition of Mead Johnson in 2017. The acquisition raises questions about liability transfer. Reckitt has argued it should not bear full responsibility for decisions made before the purchase.
Courts have generally held that acquiring companies inherit the liabilities of the companies they buy. This defense strategy has not gained much traction so far.
| Company Detail | Info |
|---|---|
| Original Manufacturer | Mead Johnson Nutrition |
| Current Parent Company | Reckitt Benckiser |
| Acquisition Year | 2017 |
| Primary Products at Issue | Enfamil Premature, Enfamil HMF |
| Defense Strategy | Regulatory compliance, multi-causal NEC argument |
Mead Johnson’s position is similar to Abbott’s: their products met FDA standards, NEC has many causes, and the scientific evidence doesn’t prove their formula was the specific trigger.
Necrotizing Enterocolitis Lawsuit
A necrotizing enterocolitis lawsuit is a legal action filed when a premature infant develops NEC and the family believes a bovine-based formula product caused or contributed to the condition. NEC is the medical condition at the heart of every preemie formula claim.
Understanding NEC is important for understanding why these lawsuits carry such emotional weight. This isn’t a minor side effect. NEC is catastrophic.
What happens during NEC:
- Bacteria invade the intestinal wall
- Tissue becomes inflamed and begins to die
- Gas can form inside the intestinal wall (pneumatosis intestinalis)
- The intestine may perforate, spilling contents into the abdomen
- Sepsis and multi-organ failure can follow rapidly
NEC is staged using the modified Bell’s criteria. Stage 1 is suspected NEC. Stage 2 is definite NEC with confirmed diagnosis. Stage 3 is advanced NEC requiring surgery, often with perforation.
| NEC Stage | Description | Treatment |
|---|---|---|
| Stage 1 (Suspected) | Mild symptoms, possible NEC | NPO, antibiotics, observation |
| Stage 2 (Definite) | Confirmed NEC, pneumatosis | NPO, IV antibiotics, serial imaging |
| Stage 3 (Advanced) | Perforation or peritonitis | Emergency surgery, possible bowel resection |
For lawsuits, Stage 2 and Stage 3 cases are generally the ones that qualify. Stage 1 cases are harder to litigate because the diagnosis is less certain and the outcomes are usually less severe.
Survivors of Stage 3 NEC often lose significant portions of their intestine. This can lead to short bowel syndrome, a lifelong condition requiring specialized nutrition support. Some children need intestinal transplants.
The suffering is real. The medical bills are staggering. That’s why these lawsuits seek significant compensation.
How to File a Preemie Formula Lawsuit
Filing a preemie formula lawsuit starts with contacting a law firm that handles NEC baby formula cases and providing them with your child’s medical records from the NICU stay. Most firms handle these cases on a contingency basis, meaning you pay nothing unless your case results in compensation.
Here’s the process broken into simple steps.
Step-by-step filing process:
- Gather medical records from the NICU, including feeding logs, NEC diagnosis, and treatment records
- Contact an experienced NEC attorney who handles preemie formula cases
- Complete a case evaluation where the attorney reviews your records
- Sign a retainer agreement if the firm accepts your case
- Your attorney files the complaint in the appropriate court
- Your case joins the MDL (MDL No. 3026) for coordinated proceedings
The timeline from initial contact to filing is usually 2 to 8 weeks. It depends on how quickly you can get your medical records. Some hospitals take weeks to process records requests.
One common mistake families make is waiting too long. Statutes of limitations vary by state, and some states have shorter windows for medical-related claims. Filing sooner protects your rights.
You don’t need to live in Illinois to join the MDL. Cases from every state are transferred to the Northern District of Illinois for pretrial proceedings. If your case goes to trial individually, it could be sent back to your home state.
Cost is not a barrier. Contingency fees mean the law firm covers all upfront costs. They take a percentage of the settlement or verdict, typically 33 to 40 percent, only if you win.
Key Takeaway: Filing a preemie formula lawsuit costs nothing upfront, starts with gathering your child’s NICU medical records, and most cases join the centralized MDL in Illinois.
Preemie Formula Lawsuit Payout
Preemie formula lawsuit payouts are expected to vary widely based on injury severity, with the most common projections placing individual settlements between $100,000 and $5 million or more. No global settlement fund has been announced yet as of early 2026.
Payouts in mass tort cases like this typically follow a tiered structure. Cases are sorted into categories based on the severity of harm. Each tier has a payout range.
Factors that determine your payout:
- Severity of the NEC diagnosis (Stage 2 vs. Stage 3)
- Whether surgery was required
- Number of surgeries performed
- Whether the infant survived
- Long-term complications (short bowel syndrome, developmental delays)
- Strength of documentation proving formula use
- State where the claim is filed
It’s helpful to compare this litigation to other mass torts. Talcum powder cases against Johnson and Johnson resulted in individual verdicts ranging from $25 million to $4.7 billion. The NEC cases involve similarly sympathetic plaintiffs.
| Payout Factor | Impact on Settlement |
|---|---|
| NEC Stage 2, recovered | Lower tier |
| NEC Stage 3, single surgery | Mid tier |
| NEC Stage 3, multiple surgeries | Upper-mid tier |
| Short bowel syndrome | High tier |
| Infant death | Highest tier |
One thing families should understand: payouts don’t happen overnight. Even after a settlement is reached, the distribution process can take 6 to 18 months. Claims have to be reviewed, verified, and processed.
If bellwether verdicts continue favoring plaintiffs, that will push settlement values higher. Every large jury award raises the floor for negotiations.
Cow Milk Formula NEC Risk
Cow milk formula increases the risk of NEC in premature infants compared to exclusive human breast milk feeding. This scientific link is the foundation of every preemie formula lawsuit filed in the MDL.
The connection isn’t new or controversial in medical circles. Neonatologists have known about it for years. The question in the lawsuits is whether the formula manufacturers knew and hid this information from hospitals and parents.
What the research shows:
- A 2011 Cochrane Review found that formula feeding was associated with a higher incidence of NEC compared to breast milk
- A landmark 1990 study by Dr. Alan Lucas found NEC was 6 to 10 times more common in formula-fed premature infants
- The American Academy of Pediatrics has recommended human milk as the preferred feeding for premature infants since at least 2012
- Multiple hospital systems have shifted to exclusive human milk diets in their NICUs, with dramatic reductions in NEC rates
The biological explanation makes sense. Breast milk contains immunoglobulins, growth factors, and beneficial bacteria that protect the premature gut. Cow’s milk protein is foreign to the infant’s system and harder for the immature intestine to process.
| Feeding Type | Estimated NEC Rate in VLBW Infants |
|---|---|
| Exclusive human breast milk | 1 to 3% |
| Mixed (breast milk + bovine fortifier) | 3 to 6% |
| Exclusive bovine-based formula | 5 to 10%+ |
VLBW = Very Low Birth Weight (under 1,500 grams)
The defense argues that NEC is multifactorial. That’s true. Prematurity itself, bacterial colonization, blood flow issues, and other factors all play a role. But the increased risk from bovine formula is well-documented and statistically significant.
Think of it this way: not every smoker gets lung cancer, but cigarettes dramatically increase the risk. The same logic applies to bovine formula and NEC.
Preemie Formula Lawsuit Eligibility
Preemie formula lawsuit eligibility requires that the infant was born premature, received a cow’s milk-based formula or fortifier in the NICU, and was diagnosed with NEC at Stage 2 or higher. Both surviving children and families who lost infants to NEC can file claims.
Not every NEC case qualifies. The lawsuit specifically targets injuries linked to bovine-based products. If your baby developed NEC but was never fed formula or bovine fortifiers, the claim against these manufacturers is much weaker.
Eligibility checklist:
- Born before 37 weeks gestational age: YES/NO
- Fed Similac or Enfamil bovine formula or fortifier in NICU: YES/NO
- Diagnosed with NEC Stage 2 or Stage 3: YES/NO
- NEC diagnosis documented in medical records: YES/NO
- Statute of limitations has not expired in your state: YES/NO
- Have access to NICU feeding records: YES/NO
If you answered YES to all six, you likely have a viable claim.
Statutes of limitations are a real concern. These deadlines vary by state and can range from 1 to 6 years from the date of injury or discovery. Some states have special rules for minors that extend the filing window.
| State Example | Statute of Limitations for Minors |
|---|---|
| California | Up to age 19 (2 years after turning 18) |
| Texas | Until age 20 (2 years after turning 18) |
| New York | Until age 21 (3 years after turning 18) |
| Florida | Until age 25 (tolled during minority + 4 years) |
| Illinois | Until age 20 (2 years after turning 18) |
These are simplified examples. Actual deadlines depend on case specifics and state law nuances.
Even if you think the deadline may have passed, it’s worth checking. Discovery rules, minor tolling provisions, and other exceptions can extend your window.
Key Takeaway: You likely qualify for the preemie formula lawsuit if your premature infant was fed bovine formula in the NICU and diagnosed with NEC Stage 2 or higher, but statute of limitations deadlines vary by state and should be checked immediately.
NEC Lawsuit Bellwether Trials
NEC lawsuit bellwether trials are test cases selected to go to trial before the full MDL reaches a global settlement. These trials help both sides evaluate how juries respond to the evidence, and they heavily influence settlement negotiations.
Think of bellwether trials like the opening act at a concert. They set the tone for everything that follows. If plaintiffs win big, defendants face pressure to settle. If defendants win, it weakens the overall litigation.
In this MDL, bellwether trial selection has been a contested process. Both sides want cases that favor their narrative. Judge Pallmeyer has worked to select a balanced set of representative cases.
Bellwether trial status as of 2026:
- Initial bellwether cases were selected from the overall case pool
- The first trials focused on cases involving the most severe injuries
- Jury verdicts from late 2025 and early 2026 have shaped the settlement landscape
- Additional bellwether trials are scheduled throughout 2026
The outcomes of these trials carry enormous weight. A single large verdict can shift the entire settlement calculus. Defendants who face a $10 million or higher jury award start doing the math on what a global settlement would cost versus the risk of losing hundreds of individual trials.
| Trial Phase | Purpose |
|---|---|
| Case Selection | Choose representative cases from the MDL pool |
| Discovery and Motions | Both sides prepare evidence and argue pretrial issues |
| Trial | Jury hears evidence and delivers a verdict |
| Post-Trial | Verdict informs settlement negotiations for remaining cases |
Bellwether results are not binding on other cases in the MDL. But they create a powerful psychological and financial incentive for resolution.
Preemie Formula Lawsuit Evidence Needed
The evidence needed for a preemie formula lawsuit centers on three things: proof that the infant was fed bovine-based formula, documentation of the NEC diagnosis, and records showing the severity of injury or death. Strong documentation is the single biggest factor separating high-value claims from weak ones.
You don’t need a perfect paper trail. But the more documentation you have, the stronger your case.
Essential evidence to gather:
- NICU feeding logs: These show exactly what your baby was fed each day, including formula brand and volume
- Medical records: Admission records, radiology reports (abdominal X-rays showing pneumatosis), surgical notes, pathology reports
- NEC diagnosis documentation: Physician notes confirming Bell’s Stage 2 or 3 NEC
- Discharge summary: Details about the infant’s condition at discharge
- Death certificate: If applicable, listing NEC or complications as cause of death
- Pharmacy records: Hospital records showing which formula products were ordered
Getting NICU records can take time. Hospitals typically respond to records requests within 30 to 60 days. Some charge copying fees. Start this process as soon as possible.
| Evidence Type | Why It Matters | Where to Get It |
|---|---|---|
| Feeding logs | Proves formula brand exposure | NICU medical records |
| X-ray/imaging reports | Confirms NEC diagnosis | Radiology department |
| Surgical notes | Shows severity and intervention | Hospital medical records |
| Pathology reports | Confirms tissue damage | Hospital pathology department |
| Death certificate | Documents fatal outcome | State vital records office |
One overlooked piece of evidence: your own notes. If you kept a journal during your baby’s NICU stay, wrote emails to family about what was happening, or took photos of your baby’s chart, all of it can support your case.
Your attorney will help organize this evidence. But the faster you can pull the records together, the faster your case moves forward.
Abbott Laboratories NEC Lawsuit
The Abbott Laboratories NEC lawsuit represents the claims filed against the maker of Similac products, one of the two primary defendants in the preemie formula MDL. Abbott is a Fortune 500 healthcare company headquartered in Abbott Park, Illinois.
Abbott’s Similac brand dominates the U.S. infant formula market. The company generated approximately $8 billion in pediatric nutrition revenue in recent years. The NICU-specific products represent a smaller but legally significant portion of that business.
Key allegations against Abbott:
- Abbott knew that bovine-based formula increased NEC risk in premature infants
- Internal company research and communications allegedly acknowledged the risk
- Abbott failed to include NEC warnings on product labels
- Abbott aggressively marketed its NICU products to hospitals
- Abbott did not adequately inform healthcare providers about safer alternatives
Abbott’s defense strategy has been consistent. The company argues that:
- Its products met all FDA requirements
- NEC is caused by multiple factors, not just formula
- The scientific evidence linking formula to NEC is not conclusive
- Hospital feeding decisions are made by physicians, not formula companies
The FDA argument is interesting but limited. Meeting regulatory requirements is a minimum standard. It doesn’t protect a company from liability if it knew about a risk and chose not to disclose it. That’s the failure-to-warn theory at the core of these cases.
| Abbott Detail | Info |
|---|---|
| Headquarters | Abbott Park, Illinois |
| Key Products at Issue | Similac Special Care, Similac HMF |
| Estimated Annual Nutrition Revenue | ~$8 billion |
| Legal Defense | FDA compliance, multifactorial NEC causation |
| MDL Status | Active defendant in MDL 3026 |
Abbott has significant financial resources to fight this litigation. But the volume of cases and the bellwether trial outcomes are creating real settlement pressure.
Key Takeaway: Abbott Laboratories faces claims that it knew Similac products increased NEC risk in premature infants and intentionally failed to warn hospitals or parents about the danger.
Mead Johnson NEC Lawsuit
The Mead Johnson NEC lawsuit targets the manufacturer of Enfamil products, now a subsidiary of the British consumer goods company Reckitt Benckiser. Mead Johnson was an independent company for decades before Reckitt acquired it in 2017 for approximately $16.6 billion.
That acquisition is relevant because Reckitt inherited Mead Johnson’s liabilities. Every decision Mead Johnson made about labeling, marketing, and risk disclosure before 2017 is now Reckitt’s legal problem.
Key allegations against Mead Johnson:
- Mead Johnson was aware of research linking bovine formula to NEC
- The company did not warn hospitals or parents about the increased NEC risk
- Enfamil products were marketed as safe for premature infants without appropriate risk disclosures
- Mead Johnson prioritized market share in the NICU formula space over patient safety
Mead Johnson’s defense mirrors Abbott’s in many ways. The company argues regulatory compliance, scientific uncertainty, and the multifactorial nature of NEC.
One unique aspect of the Mead Johnson cases: some plaintiffs have argued that Reckitt’s due diligence before the acquisition should have flagged the NEC litigation risk. This suggests Reckitt knowingly purchased a company with pending liability exposure.
| Mead Johnson Detail | Info |
|---|---|
| Original Headquarters | Evansville, Indiana |
| Parent Company | Reckitt Benckiser (since 2017) |
| Key Products at Issue | Enfamil Premature, Enfamil HMF |
| Acquisition Price | ~$16.6 billion |
| Legal Defense | FDA compliance, pre-acquisition decisions |
Reckitt’s stock has felt the impact of this litigation. Investor analysts have flagged the NEC lawsuits as a material risk in the company’s financial disclosures. The potential settlement cost is a significant line item.
Both Abbott and Mead Johnson are major defendants. But the dynamics are slightly different because of the Reckitt acquisition layer.
Frequently Asked Questions
How much money can I get from the preemie formula lawsuit in 2026?
Most estimates place individual settlements between $50,000 and $5 million or more.
The exact amount depends on injury severity, whether surgery was required, and whether the infant survived.
No global settlement has been finalized yet, but bellwether trial results are pushing values higher.
What is the deadline to file a preemie formula NEC lawsuit?
Filing deadlines depend on your state’s statute of limitations, which ranges from 1 to 6 years from the injury or discovery date.
Most states extend deadlines for minors, often until 2 years after the child turns 18.
Contact an attorney now to confirm your specific deadline before it passes.
Does my child qualify for the preemie formula lawsuit?
Your child likely qualifies if they were born premature, fed Similac or Enfamil bovine formula or fortifier in the NICU, and diagnosed with NEC Stage 2 or higher.
Both surviving children and families who lost infants can file claims.
Medical records from the NICU confirming formula use and NEC diagnosis are required.
What formula brands are involved in the NEC lawsuit?
The two main brands are Similac (made by Abbott Laboratories) and Enfamil (made by Mead Johnson, now owned by Reckitt Benckiser).
Specific products include Similac Special Care, Similac Human Milk Fortifier, Enfamil Premature, and Enfamil Human Milk Fortifier.
These are bovine-based products designed for premature infants in NICUs.
How long will the preemie formula lawsuit take to settle?
A global settlement could emerge in late 2026 or 2027, depending on bellwether trial outcomes and mediation progress.
Individual settlements may take longer, with distribution happening 6 to 18 months after any agreement.
Cases filed sooner are positioned better for early settlement rounds.
This litigation is moving. 2026 is shaping up as a pivotal year for the preemie formula lawsuit, with bellwether trials driving settlement momentum.
If your premature infant was fed bovine-based formula and developed NEC, now is the time to act. Pull your NICU records. Talk to an attorney. Get your claim on file.
Families have waited long enough. The window to file is open, but deadlines are real. Don’t let yours pass.
